PRNewsWire
05 Nov 2025, 01:06 UTC · 50w ago
Verdict
Headline takes no side. We score BHVN −1.00 — strongly bearish.
−1.00strongly bearish
More negative than 96% of ticker scores this week
Which stocks this story touches
More negative than 96% of ticker scores this week
The company received a Complete Response Letter from the FDA, resulting in the rejection of its New Drug Application for VYGLXIA.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Search tags
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Proactive Investors
2d ago
−15.8%
Price agrees with the score
$11.75 vs $13.95 close before publication (Nov 4) · not market-adjusted
BHVN chart →
